Almirall SA ($GB:0O9B) announced an update on their ongoing clinical study. Study Overview: Almirall S.A. is running a phase 2 trial called “A ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the target population," the authors concluded. "Furthermore, these results ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

A new study suggests that the practice of taking very small amounts of psychedelics may assist individuals in adopting ...

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...

Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.

Researchers at the University of New South Wales Sydney are testing a new way to treat chronic nerve pain by training the ...